Leap Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Leap Therapeutics's estimated annual revenue is currently $8.5M per year.
- Leap Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Leap Therapeutics has 55 Employees.
- Leap Therapeutics grew their employee count by 49% last year.
Leap Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | President & CEO | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | Chief Medical Officer | Reveal Email/Phone |
5 | Chief Scientific Officer | Reveal Email/Phone |
6 | Chief Manufacturing Officer | Reveal Email/Phone |
7 | Chief Operating Officer | Reveal Email/Phone |
8 | VP, Program & Alliance Management | Reveal Email/Phone |
9 | VP, Biomedical Operations and Head Biometrics | Reveal Email/Phone |
10 | VP, Regulatory Affairs & Quality | Reveal Email/Phone |
Leap Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Leap Therapeutics?
Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. For more information about Leap Therapeutics, visit http://www.leaptx.com or our public filings with the SEC that are available via EDGAR at http://www.sec.gov or via http://www.investors.leaptx.com.
keywords:N/AN/A
Total Funding
55
Number of Employees
$8.5M
Revenue (est)
49%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.7M | 55 | 31% | $153M |
#2 | $4.3M | 55 | -68% | $377.5M |
#3 | N/A | 55 | 400% | N/A |
#4 | $15M | 56 | 17% | N/A |
#5 | $11.1M | 56 | 22% | N/A |